Page results
-
The Charles Dent Metabolic Unit (CDMU) is one of the largest and longest established services in the world for the treatment of adolescents and adults (aged 16 years and older) with inherited metabolic diseases.
-
A clinic for neurology patients with long COVID
-
Dr Riaz' clinical practice includes a wide range of radionuclide diagnostic and therapeutic procedures, including conventional Nuclear Medicine imaging, oncologic and non-oncological PET imaging, cardiac PET imaging, and radionuclide therapies for thyroid cancer, prostate cancer and other rare cancers.
-
Information about incentive spirometry (IS) for adults with sickle cell disorder.
-
Support patients in hospital this Christmas and the staff looking after them by donating to our UCLH Charity Gift of Giving Appeal.
-
The Royal National Ear Nose and Throat Hospital is a national and international centre for voice disorders. The voice service includes four consultant laryngologists, eight speech and language therapists and specialist nurses.
-
Gastro-oesophageal reflux (GOR) is the effortless regurgitation of feeds/milk. It affects over 40% of babies.
-
Information about Lutetium-177 PSMA radionuclide therapy for metastatic or treatment-resistant prostate cancer
-
Dr Lynch is a consultant neurologist at the National Hospital for Neurology and Neurosurgery. He sees patients with all types of neurological disease in his general neurology clinics, and he has a particular interest in patients with inherited disorders of white matter, also called leukodystrophies
-
This information is for children and young people with Type 1 diabetes, and their families, on how to manage high glucose levels when using hybrid closed loop (HCL) systems.
File results
-
FOI/2022/0212 - Clotting disorders medication
-
FOI/2022/0214 - Prostate Cancer (Summary Funding and costs of Xtandi (Enzalutamide) trial: NCT00974311) Xtandi (Enzalutamide) trial, NCT00974311
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0221 - Asthma medications
-
FOI/2022/0223 - Policies/ procedures for management of patients with chest pain
-
FOI/2022/0224 - Procurement for physiotherapy, occupational therapy, pharmacy, radiography, speech and language therapy and sterile services
-
FOI/2022/0226 - Treatments for Haemophilia A
-
FOI/2022/0227 - Number of cancer trackers and cancer MDT co-ordinators at Trust
-
FOI/2022/0230 - Fabry, Gaucher and Pompe diseases drug treatments
-
FOI/2022/0232 - Number of patients who have died while waiting for elective care